These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 25572590)
1. XAGE-1b cancer/testis antigen is a potential target for immunotherapy in prostate cancer. Xie C; Wang G Urol Int; 2015; 94(3):354-62. PubMed ID: 25572590 [TBL] [Abstract][Full Text] [Related]
2. A dendritic cell-based tumour vaccine for lung cancer: full-length XAGE-1b protein-pulsed dendritic cells induce specific cytotoxic T lymphocytes in vitro. Zhou Q; Guo AL; Xu CR; An SJ; Wang Z; Yang SQ; Wu YL Clin Exp Immunol; 2008 Sep; 153(3):392-400. PubMed ID: 18803763 [TBL] [Abstract][Full Text] [Related]
3. XAGE-1 expression in non-small cell lung cancer and antibody response in patients. Nakagawa K; Noguchi Y; Uenaka A; Sato S; Okumura H; Tanaka M; Shimono M; Ali Eldib AM; Ono T; Ohara N; Yoshino T; Yamashita K; Tsunoda T; Aoe M; Shimizu N; Nakayama E Clin Cancer Res; 2005 Aug; 11(15):5496-503. PubMed ID: 16061866 [TBL] [Abstract][Full Text] [Related]
4. Promoting effects on the proliferation and metastasis of ACC tumor cell with XAGE-1b overexpression. Zhou B; Li T; Liu Y; Zhu N Oncol Rep; 2013 Nov; 30(5):2323-35. PubMed ID: 24008415 [TBL] [Abstract][Full Text] [Related]
5. Spontaneous antibody, and CD4 and CD8 T-cell responses against XAGE-1b (GAGED2a) in non-small cell lung cancer patients. Ohue Y; Eikawa S; Okazaki N; Mizote Y; Isobe M; Uenaka A; Fukuda M; Old LJ; Oka M; Nakayama E Int J Cancer; 2012 Sep; 131(5):E649-58. PubMed ID: 22109656 [TBL] [Abstract][Full Text] [Related]
6. Immune Responses to the Cancer Testis Antigen XAGE-1b in Non Small Cell Lung Cancer Caucasian Patients. Saito K; Nakayama E; Valmori D PLoS One; 2016; 11(3):e0150623. PubMed ID: 26937656 [TBL] [Abstract][Full Text] [Related]
7. Identification of XAGE-1 isoforms: predominant expression of XAGE-1b in testis and tumors. Sato S; Noguchi Y; Ohara N; Uenaka A; Shimono M; Nakagawa K; Koizumi F; Ishida T; Yoshino T; Shiratori Y; Nakayama E Cancer Immun; 2007 Mar; 7():5. PubMed ID: 17335148 [TBL] [Abstract][Full Text] [Related]
8. Immunoscreening of a cDNA library from a lung cancer cell line using autologous patient serum: Identification of XAGE-1b as a dominant antigen and its immunogenicity in lung adenocarcinoma. Ali Eldib AM; Ono T; Shimono M; Kaneko M; Nakagawa K; Tanaka R; Noguchi Y; Nakayama E Int J Cancer; 2004 Feb; 108(4):558-63. PubMed ID: 14696120 [TBL] [Abstract][Full Text] [Related]
9. Characterization of XAGE-1b, a short major transcript of cancer/testis-associated gene XAGE-1, induced in melanoma metastasis. Zendman AJ; van Kraats AA; den Hollander AI; Weidle UH; Ruiter DJ; van Muijen GN Int J Cancer; 2002 Jan; 97(2):195-204. PubMed ID: 11774264 [TBL] [Abstract][Full Text] [Related]
10. Lack of XAGE-1b and NY-ESO-1 in metastatic lymph nodes may predict the potential survival of stage III melanoma patients. Mori M; Funakoshi T; Kameyama K; Kawakami Y; Sato E; Nakayama E; Amagai M; Tanese K J Dermatol; 2017 Jun; 44(6):671-680. PubMed ID: 28105694 [TBL] [Abstract][Full Text] [Related]
11. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice. Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311 [TBL] [Abstract][Full Text] [Related]
12. Characterization of overlapping XAGE-1 transcripts encoding a cancer testis antigen expressed in lung, breast, and other types of cancers. Egland KA; Kumar V; Duray P; Pastan I Mol Cancer Ther; 2002 May; 1(7):441-50. PubMed ID: 12479262 [TBL] [Abstract][Full Text] [Related]
13. Local and systemic XAGE-1b-specific immunity in patients with lung adenocarcinoma. Talebian Yazdi M; Loof NM; Franken KL; Taube C; Oostendorp J; Hiemstra PS; Welters MJ; van der Burg SH Cancer Immunol Immunother; 2015 Sep; 64(9):1109-21. PubMed ID: 26025564 [TBL] [Abstract][Full Text] [Related]
14. [Adaptive immunotherapy of the advanced prostate cancer - cancer testis antigen (CTA) as possible target antigens]. Prikler L; Scandella E; Men Y; Engeler DS; Diener PA; Gillessen S; Ludewig B; Schmid HP Aktuelle Urol; 2004 Aug; 35(4):326-30. PubMed ID: 15459874 [TBL] [Abstract][Full Text] [Related]
15. Computational prediction of vaccine potential epitopes and 3-dimensional structure of XAGE-1b for non-small cell lung cancer immunotherapy. Tarek MM; Shafei AE; Ali MA; Mansour MM Biomed J; 2018 Apr; 41(2):118-128. PubMed ID: 29866600 [TBL] [Abstract][Full Text] [Related]
16. [Association of XAGE-1b gene expression with clinical characteristics of non-small cell lung cancer]. Zhou Q; Guo AL; An SJ; Xu CR; Yang SQ; Wu YL Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):966-8. PubMed ID: 17666327 [TBL] [Abstract][Full Text] [Related]
17. Genetic variants of immunoglobulin γ and κ chains influence humoral immunity to the cancer-testis antigen XAGE-1b (GAGED2a) in patients with non-small cell lung cancer. Pandey JP; Namboodiri AM; Ohue Y; Oka M; Nakayama E Clin Exp Immunol; 2014 Apr; 176(1):78-83. PubMed ID: 24304136 [TBL] [Abstract][Full Text] [Related]
18. Dendritic cells transfected with interleukin-12 and pulsed with tumor extract inhibit growth of murine prostatic carcinoma in vivo. Zhang S; Zeng G; Wilkes DS; Reed GE; McGarry RC; Eble JN; Cheng L Prostate; 2003 Jun; 55(4):292-8. PubMed ID: 12712408 [TBL] [Abstract][Full Text] [Related]
19. Identification of DR9-restricted XAGE antigen on lung adenocarcinoma recognized by autologous CD4 T-cells. Shimono M; Uenaka A; Noguchi Y; Sato S; Okumura H; Nakagawa K; Kiura K; Tanimoto M; Nakayama E Int J Oncol; 2007 Apr; 30(4):835-40. PubMed ID: 17332921 [TBL] [Abstract][Full Text] [Related]
20. Activation of human cancer/testis antigen gene, XAGE-1, in tumor cells is correlated with CpG island hypomethylation. Lim JH; Kim SP; Gabrielson E; Park YB; Park JW; Kwon TK Int J Cancer; 2005 Aug; 116(2):200-6. PubMed ID: 15800911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]